Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients: results from a survey study in the Netherlands

M. Timmermans, G. S. Sonke, W. J. van Driel, R. I. Lalisang, P. B. Ottevanger, C. D. de Kroon, K. K. Van de Vijver, M. A. van der Aa, R. F. Kruitwagen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)98-102
Number of pages5
JournalEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
Volume223
DOIs
Publication statusPublished - 1 Apr 2018

Keywords

  • Epithelial ovarian cancer
  • Primary debulking surgery
  • Neoadjuvant chemotherapy
  • Survey
  • ADVANCED-STAGE OVARIAN
  • HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
  • GYNECOLOGIC-ONCOLOGY
  • EUROPEAN-SOCIETY
  • CANCER
  • SURVIVAL
  • CISPLATIN
  • TRIAL
  • PACLITAXEL
  • MANAGEMENT

Cite this